In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer

Molecules

Volumn 18, Issue 9, 2013, Pages 10580-10598

  Kamba, Shafiu Abdullahi ^a   Ismail, Maznah ^a   Hussein Al Ali, Samer Hasan ^a   Ibrahim, Tengku Azmi Tengku ^a   Zakaria, Zuki Abu Bakar ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Calcium carbonate; Doxorubicin; Drug delivery; Nanocrystals; Osteosarcoma

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; APOPTOSIS REGULATORY PROTEIN; CALCIUM CARBONATE; CASPASE; DELAYED RELEASE FORMULATION; DOXORUBICIN; LACTATE DEHYDROGENASE; NANOPARTICLE;

APOPTOSIS; BONE NEOPLASMS; CELL PROLIFERATION; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; DRUG FORMULATION; DRUG SCREENING; DRUG STABILITY; HUMAN; METABOLISM; OSTEOSARCOMA; PH; PHARMACOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE; X RAY CRYSTALLOGRAPHY; ARTICLE; BONE TUMOR; DRUG EFFECT;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BONE NEOPLASMS; CALCIUM CARBONATE; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CRYSTALLOGRAPHY, X-RAY; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG COMPOUNDING; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; L-LACTATE DEHYDROGENASE; NANOPARTICLES; OSTEOSARCOMA;

EID: 84885152117     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules180910580     Document Type: Article

References (28)

1. Patil, R.; Portilla-Arias, J.; Ding, H.; Konda, B.; Rekechenetskiy, A.; Inoue, S.; Black, K.L.; Holler, E.; Ljubimova, J.Y. Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(ßL-Malic Acid). Int. J. Mol. Sci. 2012, 13, 11681-11693.
2. Minko, T.; Kopečková, P.; Kopeček, J. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int. J. Cancer 2000, 86, 108-117. (Pubitemid 30133995)
3. Fan, H.; Alekha, K.D. Effect of cross-linking on the in vitro release kinetics of doxorubicin from gelatin implants. Int. J. Pharm. 2001, 213, 103-116. (Pubitemid 32119466)
4. 4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery. Int. J. Nanomed. 2012, 7, 1697-1708.
5. Spina, A.; Sorvillo, L.; Maiolo, F.D.; Esposito, A.; D'Auria, R.; Gesto D. D.; Chiosiet, E.; Naviglio, S. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway. J. Cell. Physiol. 2013, 228, 198-206.
6. Min, K.H.; Lee, H.J.; Kim, K.; Kwon, I.C.; Jeong, S.Y.; Lee, S.C. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Biomaterials 2012, 33, 5788-5797.
7. Awang-Hazmi, A.J.; Zuki, A.B.Z.; Nordin, M.M.; Jalila, A.; Norimah, Y. Mineral composition of the cockle (anadara granosa) shells of west coast of peninsular Malaysia and its potential as biomaterial for use in bone repair. J. Anim. Vet. Adv. 2007, 6, 591-594.
8. Islam, K.N.; Zuki, A.B.Z.; Wahid, H.; Ali, M.E.; Hussein, M.Z.B.; Noordin, M.M.; Loqman, M.Y.; Wahid, H.; Hakim, M.A.; Hamid, S.B.A. Facile synthesis of calcium carbonate nanoparticles from cockle shells. J. Nanomater. 2012, 2012, 2.
9. Kamba, A.S.; Ismail, M.; Ibrahim, T.A.T.; Zakaria, Z.A.B. Synthesis and characterisation of calcium carbonate aragonite nanocrystals from cockle shell powder (anadara granosa). J. Nanomater. 2013, 2013, 398357:1-398357:9.
10. Naruphontjirakul, P.; Viravaidya-Pasuwat, K. Development of doxorubicin-Core shell o-succinyl chitosan graft pluronic®127 copolymer nanoparticles to treat human cancer. Int. J. Biosci. Biochem. Bioinforma. 2011, 1, 131-136.
11. Pharmacopoeia commission of the Peoples Republic of China. Pharmacopoeia of the Peoples Republic of China; Chemistry Industry Press, Beijing, China, 2000.
12. Wang, J.; Chen, S.; Zong, J. Y.; Zhao, D.; Li, F.; Zhuo, R. X.; Cheng, S. X. Calcium carbonate/carboxymethyl chitosan hybrid microspheres and nanospheres for drug delivery. J. Phys. Chem. C 2010, 114, 18940-18945.
13. Zhao, Q.H.; Han, B.S.; Wang, Z.H.; Gao, C.Y.; Peng, C.H.; Shen, J.C. Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: Doxorubicin loading and in vitro and in vivo studies. Nanomed. Nanotechnol. Biol. Med. 2007, 3, 63-74.
14. Cui, W.; Cui, Y.; Zhao, J.; Li, J.B.; Fabrication of tumor necrosis factor-related apoptosis inducing ligand (TRAIL)/ALG modified CaCO3 as drug carriers with the function of tumor selective recognition. J. Mater. Chem. B 2013, 1, 1326-1332.
15. Barua, S.; Yoo, J.W.; Kolhar, P.; Wakankar, A.; Gokarn, Y.R.; Mitragotri, S. Particle shape enhances specificity of antibody-displaying nanoparticles. Proc. Natl. Acad. Sci. USA 2013, 110, 10753-10758.
16. Gillies, E.R.; Fréchet J.M.J. pH-responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug. Chem. 2005, 16, 361-368. (Pubitemid 40388212)
17. Chittasupho, C.; Xie, S.X.; Baoum, A.; Yakovleva, T.; Siahaan, T.J.; Berkland, C.J. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur. J. Pharm. Sci. 2009, 37, 141-150.
18. Larsen, A.K.; Escargueil, A.E.; Skladanowski, A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol. Ther. 2000, 85, 217-229. (Pubitemid 30160791)
19. Mohan, P.; Rapoport, N. Doxorubicin as a molecular nanotheranostic agent: Effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol. Pharm. 2010, 7, 1959-1973.
20. Manaspon, C.; Viravaidya-Pasuwat, K.; Pimpha, N. Preparation of folate-conjugated pluronic F127/chitosan core-shell nanoparticles encapsulating doxorubicin for breast cancer treatment. J. Nanomater. 2012, 2012, 593878.
21. Liang, P.; Zhao, D.; Wang, C.Q.; Zong, J.Y.; Zhuo, R.X.; Cheng, S.X. Facile preparation of heparin/CaCO3/CaP hybrid nano-carriers with controllable size for anticancer drug delivery. Colloids Surf. B Biointerfaces 2013, 102, 783-788.
22. Upadhyay, K.K.; Bhatt, A. N.; Mishra, A. K.; Dwarakanath, B.S.; Jain, S.; Schatz, C.; Meins, J.F.L.; Farooque, A.; Chandraiah, G.; Misra, A.; et al. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(g-benzyl L-glutamate)-b-hyaluronan polymersomes. Biomaterials 2010, 31, 2882-2892.
23. Shuai, X.T.; Ai, H.; Nasongkla, N.; Kim, S.; Gao, J.M. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control. Release 2004, 98, 415-426. (Pubitemid 39093952)
24. Zheng, C; Qiu, L; Yao, X; Zhu, K. Novel micelles from graft polyphosphazenes as potential anti-cancer drug delivery systems: Drug encapsulation and in vitro evaluation. Int. J. Pharm. 2009, 373, 133-140.
25. 3 hybrid nanoparticles for efficient co-delivery of antitumor gene and drug. Mol. Pharm. 2012, 9, 2887-2893.
26. Selim, M.E.; Hendi, A.A. Gold nanoparticles induce apoptosis in MCF-7 human breast cancer cells. Asian Pac. J. Cancer Prev. 2012, 13, 1617-1620.
27. Lanvin, O.; Gouilleux, F.; Mullié, C.; Fuentes, V.; Bissac, E.; Dantin, F.; Mazière, J.C.; Régnier, A.; Lassoued, K.; Gouilleux-Gruart, V. Interleukin-7 induces apoptosis of 697 pre-B cells expressing dominant negative forms of STAT5 evidence for caspase-dependent and-independent mechanisms. Oncogene 2004, 23, 3040-3047. (Pubitemid 38659569)
28. Youle, R.J.; Strasser, A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9, 47-59.